The Prostate

Cover image for The Prostate

1 June 2008

Volume 68, Issue 8

Pages 803–918

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Research Articles
    4. Original Articles
    1. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer (pages 803–808)

      Kang Su Cho, Joong Shik Lee, Nam Hoon Cho, Kyeongmee Park, Won Sik Ham and Young Deuk Choi

      Version of Record online: 26 FEB 2008 | DOI: 10.1002/pros.20743

    2. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides (pages 809–819)

      Wei Wang, Elizabeth R. Rayburn, Miao Hao, Yuqing Zhao, Donald L. Hill, Ruiwen Zhang and Hui Wang

      Version of Record online: 6 MAR 2008 | DOI: 10.1002/pros.20742

  2. Research Articles

    1. Top of page
    2. Original Articles
    3. Research Articles
    4. Original Articles
    1. RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model (pages 820–829)

      K. M. Woods Ignatoski, J. F. Escara-Wilke, J.-L. Dai, A. Lui, W. Dougall, S. Daignault, Z. Yao, J. Zhang, M. L. Day, E. E. Sargent and E. T. Keller

      Version of Record online: 6 MAR 2008 | DOI: 10.1002/pros.20744

  3. Original Articles

    1. Top of page
    2. Original Articles
    3. Research Articles
    4. Original Articles
    1. Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential (pages 830–838)

      Carmela Ricciardelli, Michael W. Jackson, Catherine S. Choong, Jürgen Stahl, Villis R. Marshall, David J. Horsfall and Wayne D. Tilley

      Version of Record online: 6 MAR 2008 | DOI: 10.1002/pros.20747

    2. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes (pages 839–848)

      Bo-Ying Bao, Bin-Fay Chuang, Qianben Wang, Oliver Sartor, Steven P. Balk, Myles Brown, Philip W. Kantoff and Gwo-Shu Mary Lee

      Version of Record online: 26 FEB 2008 | DOI: 10.1002/pros.20749

    3. In vivo and in vitro studies of anticancer actions of α-TEA for human prostate cancer cells (pages 849–860)

      Li Jia, Weiping Yu, Pei Wang, Bob G. Sanders and Kimberly Kline

      Version of Record online: 6 MAR 2008 | DOI: 10.1002/pros.20750

    4. RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid (pages 861–871)

      Todd M. Morgan, Tiffany E.M. Pitts, Ted S. Gross, Sandra L. Poliachik, Robert L. Vessella and Eva Corey

      Version of Record online: 24 MAR 2008 | DOI: 10.1002/pros.20752

    5. Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation (pages 872–882)

      Kazutoshi Fujita, Charles M. Ewing, Lori J. Sokoll, Debra J. Elliott, Mark Cunningham, Angelo M. De Marzo, William B. Isaacs and Christian P. Pavlovich

      Version of Record online: 24 MAR 2008 | DOI: 10.1002/pros.20755

    6. Characterization of PacMetUT1, a recently isolated human prostate cancer cell line (pages 883–892)

      D.A. Troyer, Y. Tang, R. Bedolla, S.G. Adhvaryu, I.M. Thompson, S. Abboud-Werner, L.-Z. Sun, W.E. Friedrichs and L.A. deGraffenried

      Version of Record online: 24 MAR 2008 | DOI: 10.1002/pros.20758

    7. Endothelial cells support the growth of prostate tissue in vivo (pages 893–901)

      Michael Bates, Bruce Kovalenko, E. Lynette Wilson and David Moscatelli

      Version of Record online: 24 MAR 2008 | DOI: 10.1002/pros.20762

    8. Genetic changes and DNA damage responses in the prostate (pages 902–918)

      Taija M. Kiviharju-af Hällström and Marikki Laiho

      Version of Record online: 6 MAR 2008 | DOI: 10.1002/pros.20746

SEARCH

SEARCH BY CITATION